- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/16 - Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
Patent holdings for IPC class A61P 5/16
Total number of patents in this class: 98
10-year publication summary
|
4
|
0
|
2
|
5
|
8
|
10
|
14
|
6
|
6
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Philip Morris Products S.A. | 7519 |
4 |
| Daiichi Sankyo Company, Limited | 1852 |
4 |
| Hinova Pharmaceuticals Inc. | 94 |
4 |
| F. Hoffmann-La Roche AG | 7926 |
3 |
| Vertex Pharmaceuticals Incorporated | 1596 |
3 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 820 |
3 |
| KPC Pharmaceuticals, Inc. | 25 |
3 |
| Shanghai Kunheng Pharma-tech Co., Ltd | 9 |
3 |
| Jiangsu Hengrui Medicine Co., Ltd. | 706 |
2 |
| Kissei Pharmaceutical Co., Ltd. | 184 |
2 |
| Osaka University | 3362 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 628 |
2 |
| Sunshine Lake Pharma Co., Ltd. | 588 |
2 |
| Academy of Military Medical Sciences | 122 |
2 |
| Regcell Co., Ltd. | 16 |
2 |
| Bristol-myers Squibb Company | 4892 |
1 |
| Takeda Pharmaceutical Company Limited | 2704 |
1 |
| University of Florida Research Foundation, Inc. | 3989 |
1 |
| Carna Biosciences, Inc. | 61 |
1 |
| The Chemo-Sero-Therapeutic Research Institute | 48 |
1 |
| Other owners | 52 |